Versions Compared

Old Version 19

changes.mady.by.user Former WMDA staff member

Saved on

compared with

New Version 20

changes.mady.by.user Former WMDA staff member

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

IDM Testing at donor workup (please fill in Yes, On Request, No, Test method)YESOn requestNOTest method

Timeframe before stem cell donation date (for donors) or

Timeframe when the materials sample is taken for testing (for cords)

ALT/AST:

  •   
  •   
  •   


Chagas:
  •   
  •   
  •   


CMV IgG:
  •   
  •   
  •   


CMV IgM:
  •   
  •   
  •   


CMV Total:
  •   
  •   
  •   


EBV IgG:
  •   
  •   
  •   


EBV IgM:
  •   
  •   
  •   


HAV (NAT):

  •   
  •   
  •   


HBV (NAT):
  •   
  •   
  •   


HBc Ab:
  •   
  •   
  •   


HBs Ag: 
  •   
  •   
  •   


HCV (NAT):
  •   
  •   
  •   


HCV Ab:
  •   
  •   
  •   


HEV (NAT):
  •   
  •   
  •   


HIV (NAT):
  •   
  •   
  •   


HIV-1 Ab:
  •   
  •   
  •   


HIV-2 Ab:
  •   
  •   
  •   


HIV p24:
  •   
  •   
  •   


HTLV-I: 
  •   
  •   
  •   


HTLV-II:
  •   
  •   
  •   


Malaria:
  •   
  •   
  •   


HSV:
  •   
  •   
  •   


STS:
  •   
  •   
  •   


STS FTA-ABS:
  •   
  •   
  •   


Toxoplasmosis:

  •   
  •   
  •   


VZV:
  •   
  •   
  •   


WNV-NAT:
  •   
  •   
  •   


Other tests performed:
  •   
  •   
  •   



Testing

The physical and medical exam at donor work up is performed by a medical doctor:

YES / NO
All donor testing (at work up) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority:YES / NO
HLA typing for patient specific request is performed in an appropriately accredited laboratory:YES / NO
Sterility testing is performed on the adult donor product:YES / NO
Sterility testing is performed on the cord blood product:YES / NO

Reporting of Serious Adverse Events

Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in:


Additional comments
Mandatory National Reporting SchemeYES / NO

Voluntary National Reporting Scheme

YES / NO

WMDA SEAR/SPEAR Reporting Scheme:

YES / NO
The Registry will notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product?YES / NO

...